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Abstract
Background: Treatment for osteonecrosis of the femoral head (ONFH) in young individuals remains controversial.
We developed a lantern-shaped screw, which was designed to provide mechanical support for the femoral head to
prevent its collapse, for the treatment of ONFH. The purpose of this study was to investigate the efficacy and safety
of the lantern-shaped screw loaded with autologous bone for the treatment of pre-collapse stages of ONFH.
Methods: Thirty-two patients were randomly divided into two groups: the lantern-shaped screw group (core
decompression and lantern-shaped screw loaded with autogenous bone) and the control group (core decompression
and autogenous bone graft). During 36 months follow-up after surgery, treatment results in patients were assessed by
X-ray and computed tomography (CT) scanning as well as functional recovery Harris hip score (HHS).
Results: Successful clinical results were achieved in 15 of 16 hips (94%) in the lantern-shaped screw group compared
with 10 of 16 hips (63%) in the control group (p = 0.0325). Successful radiological results were achieved in 14 of 16 hips
(88%) in the lantern-shaped screw group compared with 8 of 16 hips (50%) in the control group (P = 0.0221).
Conclusion: The lantern-shaped screw loaded with autologous bone for the treatment of pre-collapse stages of ONFH
is effective and results in preventing progression of ONFH and reducing the risk of femoral head collapse.
Trial registration: The trial registration number: ChiCTR-TRC-13004078 (retrospectively registered at 2013-11-28).
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Background
Hip-preserving surgery has been variable in treating
osteonecrosis of the femoral head (ONFH), but there is
a lack of consensus on the effectiveness of joint preserving
procedures for ONFH. It is undesirable that hip replace-
ment has been undertaken for the young individuals in
whom hip prostheses have a limited survival. It is better to
preserve the femoral head than replace it [1]. The exact
mechanisms of femoral head collapse remain unclear.
One hypothesis is based on the effects of shear stress at
the boundary of necrotic and normal zones [2], and the
other is in accordance with the grade of bone resorption
at the boundary [3]. Karasuyama et al. [4] indicated that
sclerotic differences at the boundary may play a crucial
role in the pathomechanism of femoral head collapse.
Core decompression with or without bone grafting are the
most common technique for the early stages of ONFH
[5–8]. Nevertheless, the current clinical results were not
very satisfactory for patients in the early stages of ONFH
performed with core decompression due to the lack of the
sufficient structural support [9–11]. Various osteotomies
including transtrochanteric rotational osteotomy and
curved varus osteotomy have been presented well-known
to treat ONFH [12]. Nevertheless, some studies have de-
scribed various clinical results and risk factors for failure
of the osteotomies, such as nonunion of the osteotomy
and postoperative fracture of the femoral neck [13]. Por-
ous tantalum implant procedure has been used for the
management of the early stages of ONFH [14]. However,
this procedure is neither entirely effective nor can it obtain
predictable results [15–17]. It has been demonstrated that
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the implantation of a non-vascularized or vascularized fib-
ula graft is a valuable treatment option for femoral head
collapse prevention and hip function improvement in pa-
tients with pre-collapse osteonecrosis [18–21]. However,
this technique may have certain drawbacks in that the im-
planted bone flaps would result in potential postoperative
displacement. Improper post-operative weight-bearing
onto the operated hip can also lead to the loosening of the
implanted bone flaps, as well as poor bone regeneration
and fusion [19, 22, 23].
In the actual practice, an ideal implant should be guar-
anteed to contact with the bone around the tunnel of
the core decompression, as well as buttressing the sub-
chondral bone of the femoral head. Collapse of femoral
head will be less likely to occur when the implant
contacted with the subchondral bone maximally [24].
Therefore, based on this principle, researchers have de-
signed numerous devices for mechanical support of the
femoral head, such as the super elastic cage implantation
[25], the biomaterial-loaded allograft threaded cage [26],
the umbrella-shaped memory alloy femoral head support
device [27], PLGA/TCP scaffold [28], and cementation
[29]. In our study, we developed a lantern-shaped screw,
which was designed to provide the achievement of sur-
face at surface support for the femoral head to prevent
its collapse, for the treatment of ONFH. The purpose of
this study was to investigate the efficacy and safety of a
lantern-shaped screw loaded with autologous bone for
the treatment of pre-collapse stages of ONFH.
Methods
Designing of the lantern-shaped screw
In collaboration with Weigao Orthopaedic Device Co.,
Ltd. (Weihai, China) and Double Engine Medical Material
Co., Ltd. (Xiamen, China), we have designed a lantern-
shaped screw, for which we have obtained a patent (patent
number: CN103445851B). This screw is made of titanium
alloy and cannulated, which is able to be full of the au-
togenous bone. The titanium mesh installed outside the
lantern-shaped screw can be unfolded into the lantern
shape to support the subchondral bone as much as pos-
sible. Furthermore, the tail cap of angle plate is a locking
screw and can block the lantern-shaped screw back off
(Fig. 1). Biomechanical tests of the lantern-shaped screws
(n = 10) were done on the Dynacell, which is the truly
dynamic load cell, designed from the outset for measuring
dynamic loads (Instron, America). The results showed that
the deformation behavior of the unfolded titanium mesh
would not be varied until the strength of vertical compres-
sion was increased to 256.7 N (range 248–272 N). By
acting the force of 500 N on the titanium mesh, the
deformation was 1.9 mm (range 1.5–2.4 mm). These data
demonstrated that the lantern-shaped screws have the
sufficient mechanical strength to allow for the weight-
bearing activities.
Inclusion and exclusion criteria for this study
Patients were eligible for inclusion that aged 16 years to
50 years, suffered from ARCO stage II to III ONFH [19],
and necrotic lesions occupying more than the medial 2/
3 of the weight-bearing area [30]. Bone marrow oedema
on magnetic resonance imaging (MRI) in the ONFH
represents a secondary sign of subchondral fracture and
thus indicates ARCO stage III [31]. The extent of the
necrotic lesion within the femoral head was graded as
Type A, B or C using the classification on the mid-cor-
onal T1-weighted MRI scans. Type A lesions occupy less
than 1/3 of the medial weight-bearing area or show no
lesion on the mid-coronal MRI scan, Type B lesions oc-
cupy between 1/3 and 2/3 of the weight-bearing area,
and Type C lesions occupy greater than 2/3 of the
weight-bearing area [30]. Patients were excluded that
had previous pathological fracture, or infection, or se-
vere metabolic diseases, or cognitive impairment.
From January 2011 to December 2013, thirty-two pa-
tients with ONFH were eligible and enrolled into this
study. There were twenty-five males and seven females
that between 16 and 47 years of age. The duration from
Fig. 1 The lantern-shaped screw. a Photo of the folding lantern-shaped screw. b Photo of the unfolding lantern-shaped screw. c Photo of the
structure and composition of the lantern-shaped screw. d Photo of the supporting equipment for the lantern-shaped screw. e Photo of the
lantern-shaped screw and the angle plate with a locking tail cap (black arrow)
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symptom onset to surgery treatment was 9 months to
38 months (Table 1). Patients who met the inclusion
criteria were randomly divided into two groups: the
lantern-shaped screw group (core decompression and
lantern-shaped screw loaded with autogenous bone) and
the control group (core decompression and autogenous
bone graft). The randomization of the patients was done
based on randomized numbers generated by sealed-en-
velope method.
Detailed baseline patient characteristics are shown in
Table 1. No significant differences were found in the
baseline characteristics of the two groups, including pa-
tients’ age, gender, side of treated hip, body mass index,
etiology, duration of illness, ARCO stage, and preopera-
tive Harris hip score (HHS) [32].
Surgical technique
All patients underwent surgery under spinal anesthesia
or general anesthetic. After positioning of the patient in
the supine position on an orthopedic traction table, the
hip was exposed through a lateral approach, and a longi-
tudinal incision was applied. With an incision of the
subcutaneous tissue and the lateral fascia, the vastus
lateralis muscle was separated by blunt dissection, and
the proximal lateral femoral cortex was exposed. Core
decompression was performed under C-arm fluoroscope
using the standard technique [5, 6]. And then, the nec-
rotic bone was removed locally.
In the control group, the autogenous iliac-crest grafts
were implanted into the region of the necrotic core
through the bone channel. In the lantern-shaped screw
group, the autogenous iliac-crest grafts were filled into
the cannulated screw, and the rest of the autogenous
bones were implanted into the region of the necrotic
core. The bearing position of the lantern-shaped screw
was a depth of approximate 7 mm beneath the articular
cartilage surface. Then, the lantern-shaped screw was
unfolded into the lantern shape using our designed
reamer. Intraoperative C-arm fluoroscope confirmed the
adequacy of positioning of the implant in the whole
process (Fig. 2). Finally, the angle plate was fixed prior
to closing the wound.
Postoperative management and follow-up assessment
Antibiotic treatment was intravenously used within 24 h
after surgery. The patients were rapidly mobilized and
educated to be non-weight-bearing for 6 weeks. Partial
weight-bearing with crutches or a walking aid was per-
mitted for the following 6 weeks, and full-weight-bearing
walking was allowed at 12 weeks postoperatively.
Clinically they were evaluated immediately after sur-
gery and at 3, 6, 12, 24, and 36 months postoperatively.
The HHS, which was acquired preoperatively and at 12,
24, and 36 months postoperatively, was used to evaluate
the function of the hips. X-ray and computed tomog-
raphy (CT) scans of the hips were experienced at the
Table 1 Baseline patient characteristics
Characteristic Lantern-shaped screw group (n = 16) Control group (n = 16) p value
Mean age (range), yr. 31.5 ± 1.9 (16–47) 32.6 ± 1.7 (18–44) 0.6622
Female/ male, n 3/ 13 4/ 12 1.0000
Right/ left hip involved, n 9/ 7 10/ 6 0.7189
Body mass index (range), kg/cm2 24.9 ± 0.5 (21–27) 24.3 ± 0.5 (21–26) 0.3978
Etiology 0.4652
Nontraumatic, n 9 11
Traumatic, n 7 5
Duration of illness (range), mo 18.8 ± 2.0 (9–36) 20.5 ± 1.8 (11–38) 0.5379
ARCO stage (II/ III) 7/ 9 8/ 8 0.7232
Bone marrow edema of hip (III) 5 6 0.7097
Mean operation time (range), min 80.13 ± 3.3 (56–105) 71.4 ± 3.1 (45–90) 0.0621
Mean blood loss (range), mL 180.6 ± 14.9 (110–350) 158.8 ± 13.7 (90–280) 0.2892
Harris hip score
Pre-operation (range) 60.3 ± 1.8 (48–72) 61.1 ± 2.0 (48–76) 0.7457
12 months (range) 86.3 ± 0.98 (81–94) 80.8 ± 1.5 (67–90) 0.0054
24 months (range) 85.6 ± 1.3 (70–92) 79.4 ± 1.7 (64–91) 0.0078
36 months (range) 85.2 ± 1.7 (68–95) 78.2 ± 2.2 (64–93) 0.0173
Successful clinical results (%) 15 (94) 10 (63) 0.0325
Successful radiological results (%) 14 (88) 8 (50) 0.0221
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same follow-up times. The primary results of this study
were clinical and radiological failure. Clinical failure was
defined as HHS < 75 points or a requirement for subse-
quent hip surgery. New occurrence of collapse or in-
creased collapse of greater than 2 mm on X-ray during
follow-up was defined as radiological failure [11, 33, 34].
Statistical analysis
SPSS 19.0 (SPSS Company, America) statistical software
was used for statistical analysis. Baseline characteristics
were assessed using descriptive statistics. The chi-square
test was taken to compare nominal data. The t-test or
Mann-Whitney U test was used to compare metric data.
All statistical assessments were two-sided and evaluated
at the 0.05 level of statistical significance.
Results
The control group required less operation time and
blood loss, but was not statistically different from the
lantern-shaped screw group (Table 1). At 36 months
follow-up, there was a significant difference between the
preoperative and the last follow-up HHS in the lantern-
shaped screw group (p < 0.0001) and control group (P <
0.0001). HHS was significantly improved in the lantern-
shaped screw group when compared to the control
group (P = 0.0173). The proportion of successful clinical
results was significantly higher in the lantern-shaped
screw group compared with the control group. Success-
ful clinical results were achieved in 15 of 16 hips (94%)
in the lantern-shaped screw group (Fig. 3). One hip
(HHS was 68 points) required total hip replacement
because of secondary degenerative arthritis at 32 months
postoperatively, and was considered clinical failure. In
the control group, successful clinical results were
achieved in 10 of 16 hips (63%). Of the 6 hips that were
clinical failures, three hips (HHS were 64, 67, and 68
points) underwent total hip replacement because of sec-
ondary degenerative arthritis 13, 19, and 20 months after
surgery. Two (HHS were 64 and 71 points) underwent
vascularized fibular grafting at 16 and 21 months after
surgery and the remaining one (HHS was 73 points) had
not undergone any further surgery at the last follow-up.
The lantern-shaped screw group had a better radio-
logical outcome than the control group (P = 0.0221).
Successful radiological results were achieved in 14 of 16
hips (88%) in the lantern-shaped screw group com-
pared with 8 of 16 hips (50%) in the control group
(Table 1). The survival rates using requirement for
further hip surgery as an endpoint were slight higher
in the treatment group when compared with the con-
trol group (P = 0.0628; Fig. 4).
Discussion
Our primary study utilizing our designed lantern-shaped
screw for the treatment of pre-collapse stages of ONFH
has generated promising effectiveness, with salvage of
femoral head and improvement of the hip joint function
at 36 months follow-up. A certain advantage of this
screw is the achievement of surface at surface support
between the weight-bearing area and upper surface of the
lantern-shaped screw. Meanwhile, autogenous bone graft-
ing promotes the bone regeneration and reconstruction.
Preservation of the collapse of the femoral head is the
great predominant principle to treat patients with pre-
collapse stages of ONFH despite of the unestablished
pathogenesis. The rareness of bone repair microcircula-
tion will cause osteonecrosis, primarily occurring in
weight-bearing region of the femoral head [35]. How-
ever, many studies have suggested that the occurrence of
the collapse is associated with the period of repair of nec-
rotic area instead of period of ischemic necrosis [36, 37].
The repair can make the femoral head necrotic area
construct again but it can also make bone structure alter
or the mechanical properties decline in the process. The
decline of mechanical properties is correlated directly with
the collapse of the femoral head. The process of resorp-
tion of necrotic bone and replacement with new bone
happen simultaneously [38]. Motomura et al. [2] who
studied 30 femoral head specimens, found that in all of
the femoral heads, collapse consistently involved a fracture
Fig. 2 Intraoperative radiography for evaluation of surgical procedure. a Insertion of the lantern-shaped screw. b The lantern-shaped screw was
being unfolded. c The lantern-shaped screw was the achievement of surface at surface support for the subchondral bone of femoral head
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at the lateral boundary of the necrotic lesion and that
collapse began at the lateral boundary of the necrotic
lesion and the size of the necrotic lesion seemed to
contribute to its distribution. Consequently, in the clinical
practice, preventing the collapse of subchondral bone has
to be given sufficient biomechanical support and suitable
circumstances to fulfill bone repair.
For many decades, surgical interventions for the
hip-preserving have been controversial. Besides those
techniques mentioned above, Papanagiotou et al. [39]
reported a safe and effective method that non-vascularised
fibular grafting with recombinant bone morphogenetic
protein-7 for the management of ONFH in five of
seven hips. They noted early consolidation of the
non-vascularised fibular grafting and preventing col-
lapse in pre-collapse stages. Yamasaki et al. [40]
thought that it appeared to confer benefit in the re-
pair of osteonecrosis and in the prevention of collapse
by the transplantation of bone-marrow-derived mono-
nuclear cells with a porous hydroxyapatite scaffold on
early bone repair. Malizos et al. [41] introduced a technique
using two or three 4.2 mm (or later 4.7 mm) tantalum pegs
for the prevention of collapse of the necrotic lesion, finding
that the estimated mean implant survival was 60 months.
Chang et al. [42] reported that the poly (propylene
fumarate) and calcium phosphate cement were combined
to provide appropriate mechanical strength after core-de-
compressed femoral heads and offer the properties of
osteoconductivity. Therefore, all the techniques are based
on the mechanical support for the femoral head to prevent
its collapse before the bone repair.
The goal of this procedure was to provide mechanical
support of the articular surface while promoting bone
healing and remodeling, and delay or avoid total hip re-
placement. The lantern-shaped screw is made of titan-
ium with quite great intensity. Actually, the device is
designed predominantly based on one of the characteris-
tics of titanium, that is, it has great plasticity with a
ductility property of up to 50–60%. The intensity allows
the device to give sufficient support assistance and the
plasticity is responsible for the transformation from the
shape of cylinder into lantern. Furthermore, the tail
cap of angle plate is locking screw and can block the
lantern-shaped screw back off. The whole surgical
Fig. 3 Representative radiographic images from both preoperative and postoperative taken at immediately after the lantern-shaped screw
implantation and 36 months. a-c Preoperative X-ray, CT and sagittal T2-weighted magnetic resonance image showing ARCO stage III ONFH in a
man aged 29 years. d and e X-ray anteroposterior view on the day of surgery. f-h X-ray and CT scans at 36 months after surgery showing union
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procedure via the support device involved core de-
compression by decreasing intraosseous pressure to
prevent the ischaemia, reconstruction of necrotic
bone beneath the weight-bearing region, mechanical
support of the articular surface via the surface at sur-
face contact achieved by the lantern-shaped screw.
Therefore, the lantern-shaped screw can be used in
pre-collapse stages of ONFH.
Limitations
This study has several limitations. Once the bone remod-
eling has occurred, the lantern-shaped screw has certain
drawbacks in that it cannot be removed. Additionally, a
small number of patients and short period of follow-up
are the main limitations of this study. More studies with
larger sample size and longer follow-up are required to
accept the role of the lantern-shaped screw in ONFH.
Conclusion
In summary, the biomechanical property and the bone
remodeling regarding the lantern-shaped screw was veri-
fied, and the features of this device were also assessed. It
is shown that the lantern-shaped screw loaded with
autogenous bone may delay or avoid the progression of
the collapse of the cartilage for the pre-collapse stages. It
can not only provide appropriate circumstance to facili-
tate new bone remodeling but also strengthen the bio-
mechanical structure for the weight-bearing region. We
believe that the lantern-shaped screw could be used not
only for autogenous bone graft but also for injection
drugs, growth factor, mesenchymal stem cells and so on
to be effective in early stages of ONFH. Therefore, we
predict that the lantern-shaped screw could provide
mechanical support and have considerable potential for
medical application.
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